Declarations of competing interests 2022

Speakers at College meetings are asked to declare any interests which they might have relating to their presentations.

A declaration of interest in no way implies that the individual has actually been influenced by his or her secondary interest.

  • Will Ash has no interests to declare
  • Katie Legge has no interests to declare 
  • Chris Willan has no interests to declare 
  • Dr Kate Franklin has no interests to declare
  • Dr Sam Burrows has no interests to declare
  • Dr Sally Stuart has no interests to declare
  • Dr Nwaorima Kamalu has no interests to declare
  • Dr Martin Ansell has no interests to declare 
  • Dr Jonathan Davies has no interests to declare
  • Dr Vera Lees has no interests to declare 
  • Dr Jonathan Olds has no interests to declare
  • Dr Zabelle Aslanyan has no interests to declare
  • Dr Chloe Sakal has no interests to declare
  • Dr Amy Manley has not yet declared any interests
  • Dr Adrian Hayes has no interests to declare 
  • Professor Rohit Shankar has not yet declared any interests
  • Professor David Nutt has declared the following: "I am a consultant for Awakn who are developing ketamine clinics in the UK. I am a consultant for Compass pathways who are developing psilocybin for the treatment of depression"
  • Dr Angela Rouncefield has not yet declared any interests
  • Dr Richard Laugharne has not yet declared any interests
  • Dr Paul Winterbottom has no interests to declare
  • Professor Jan Melichar has declared the following: "I have provided consultancy work, presentations, training and chaired panel discussions for all the pharmaceutical companies in this area in the UK and some outside the UK. The main drugs we use are oral Buprenorphine (Indivior, Martindale), oral Methadone (Martindale) and long acting Buprenorphine (only Buvidal, from Camurus, is licensed, but Indivior have monthly Sublocade and Molteni have six monthly Sixmo). In the next year, my NHS service will provide teaching and training for long acting Buprenorphine as a UK Centre of Excellence supported by Camurus. Recent work (past 5 years) has been with the above - Indivior, Martindale, Camurus, Molteni - but also includes Althea (UK work - Cannabis prescribing), Britannia (UK work - opiate detox agent - lofexidine), Jazz Pharmaceuticals (UK - antidepressants) and USWorldMeds (US work on lofexidine)."
  • Dr Zoe Gray has no interests to declare.
  • Dr Jeremy Sandbrook has no interests to declare.
  • Dr Peter Carpenter has declared a fee for speaking at a symposium - Spoke at a ORBIS conference on autism in COVID on 1 April and received a speakers fee
  • Dr Persephone Taylor has no interests to declare.
  • Dr Geoffrey Woodin has no interests to declare.
  • Mr Tobit Emmens has no interests to declare.
  • Dr Edward Meinert has no interests to declare.
  • Dr Tom Cant has no interests to declare.
  • Mrs Tracy Lang has no interests to declare.
  • Dr Ross Runciman has no interests to declare.
  • Carolyn Trippick has no interests to declare.
  • Dr Jonathan Davies has no interests to declare.
  • Dr Nicola Taylor has no interests to declare.
  • Ibrahim Hersi has no interests to declare.
  • Dr Sally Stuart has no interests to declare.
  • Dr Chloe Sakal has no interests to declare.
  • Dr Katy Franklin has declared a sponsorship for attending a meeting, "Sponsored to virtually attend European Psychiatry Association conference (June 2022) by Takeda".
  • Dr Emily Thomas has no interests to declare.
  • Dr Zabelle Aslanyan has no interests to declare.
Read more to receive further information regarding a career in psychiatry